We’ve also to intermittently infer that veliparib given, when enhanced by temozolomide-induced SSBs even, seems to have substantially less effectiveness than solitary agent PARP inhibitors with potent PARP1 trapping activity found in an identical metastatic treatment contexts [27]
January 25, 2023
Off
We’ve also to intermittently infer that veliparib given, when enhanced by temozolomide-induced SSBs even, seems to have substantially less effectiveness…